Miguel, a 63-year-old Los Angeles teacher, recently marked the 38th anniversary of his diagnosis with HIV. The doctor had told him he would be dead in a couple of years. He lived fearful that each ...

SEATTLE (Reuters) - Full details from a pivotal trial of Gilead Sciences Inc experimental Quad HIV pill show that it caused fewer adverse side effects than the company's current three-drug pill, ...

Cabotegravir was already approved for use in England and Wales as part of a combination treatment for people living with HIV.

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. A generation has passed since the world saw ...

This is figure 4 from a paper in ACS Pharmacology & Translational Science that used a novel approach to show changes in lipid metabolism and protein expression as a result of treatment with the HIV ...

The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain.

We often encounter patients taking multiple medications, which complicates choosing safe and effective antimicrobial ...

Journavx (suzetrigine) can cause side effects ranging from mild to serious. More common side effects include muscle spasms and itchiness. If side effects from Journavx become difficult to tolerate, ...

There were still 32,000 new cases of HIV in the U.S. in 2022. And about thousands of people still die annually from AIDS. HIV ...

The Food and Drug Administration (FDA) recently approved lenacapavir for HIV prevention in both men and women. Many experts believe this twice a year treatment could be a game changer in the fight ...

HIV remains a major global health issue, affecting nearly 40 million people worldwide. Current treatments, known as antiretroviral therapy (ART), are highly effective at suppressing the virus and ...